[Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
The results of a study carried out with pindolol (Visken-Sandoz, 5 mg tablets) are reported. The study had the following objectives: 1) to assess the hypotensive effect of the drug in a group of 45 outpatients; 2) to establish effectiveness variations on the basis of the number of daily administrations and doses; 3) to monitor the behaviour of arterial pressure under effort before and after the period of the study. The results obtained show that, for hypertensive patients classifiable in WHO groups 1 and 2, pindolol is effective and recommended unconditionally for out-patient treatment. In most of the patients, two administrations a day are sufficient to maintain pressure values within acceptable limits.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D010869:Pindolol
Il trattamento ambulatoriale dell'ipertensione arteriosa "detta essenziale" con pindololo. Studio a breve termine.